ArticleMolecular diversity2026

Multi-omics, machine learning, and molecular simulation identify CD44 as a candidate target in endocrine-disrupting chemical-associated thyroid cancer progression.

Yifan Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.